Nature:与C9orf72相关神经疾病中的RNA毒性

2014-03-18 Nature中文网 Nature中文网

重复扩张(指产生一前一后重复的RNA序列的额外版本的突变)是造成40多种遗传疾病的原因,它们一般会导致神经问题和神经肌肉问题。 C9orf72六核苷酸重复扩张已被发现是造成“肌萎缩侧索硬化”(ALS)和“额颞痴呆” (FTD)这两种疾病的原因。正常的C9orf72含有多达25个重复片段,而患病者的该基因则会含有数千个。 这项研究表明,RNA毒性的增加在ALS/FTD两种疾病中是造成与C9orf

重复扩张(指产生一前一后重复的RNA序列的额外版本的突变)是造成40多种遗传疾病的原因,它们一般会导致神经问题和神经肌肉问题。

C9orf72六核苷酸重复扩张已被发现是造成“肌萎缩侧索硬化”(ALS)和“额颞痴呆” (FTD)这两种疾病的原因。正常的C9orf72含有多达25个重复片段,而患病者的该基因则会含有数千个。

这项研究表明,RNA毒性的增加在ALS/FTD两种疾病中是造成与C9orf72相关病理的原因。转录的C9orf72六核苷酸重复片段被发现以一种依赖于构形的方式与特定的核糖核蛋白如核仁蛋白相结合;因此,核仁蛋白被错误局部化,并且在功能上受损,导致“核仁应激”。

原始出处:

Aaron R. Haeusler, Christopher J. Donnelly,Goran Periz, Eric A. J. Simko,Patrick G. Shaw,Min-Sik Kim,Nicholas J. Maragakis,Juan C. Troncoso,Akhilesh Pandey,Rita Sattler,Jeffrey D. Rothstein& Jiou Wang.C9orf72 nucleotide repeat structures initiate molecular cascades of disease.Nature 507, 195–200 (13 March 2014) doi:10.1038/nature13124

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879971, encodeId=aa2c18e9971d6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 02 22:13:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426285, encodeId=db901426285bc, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Thu Mar 20 04:13:00 CST 2014, time=2014-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613950, encodeId=8ec1161395002, content=<a href='/topic/show?id=f587e438580' target=_blank style='color:#2F92EE;'>#神经疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74385, encryptionId=f587e438580, topicName=神经疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ea719457876, createdName=新生儿张玉军, createdTime=Thu Mar 20 04:13:00 CST 2014, time=2014-03-20, status=1, ipAttribution=)]
    2014-07-02 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879971, encodeId=aa2c18e9971d6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 02 22:13:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426285, encodeId=db901426285bc, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Thu Mar 20 04:13:00 CST 2014, time=2014-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613950, encodeId=8ec1161395002, content=<a href='/topic/show?id=f587e438580' target=_blank style='color:#2F92EE;'>#神经疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74385, encryptionId=f587e438580, topicName=神经疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ea719457876, createdName=新生儿张玉军, createdTime=Thu Mar 20 04:13:00 CST 2014, time=2014-03-20, status=1, ipAttribution=)]
    2014-03-20 cmsvly
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879971, encodeId=aa2c18e9971d6, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 02 22:13:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426285, encodeId=db901426285bc, content=<a href='/topic/show?id=0eba392457' target=_blank style='color:#2F92EE;'>#C9orf72#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3924, encryptionId=0eba392457, topicName=C9orf72)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=683d4051559, createdName=cmsvly, createdTime=Thu Mar 20 04:13:00 CST 2014, time=2014-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613950, encodeId=8ec1161395002, content=<a href='/topic/show?id=f587e438580' target=_blank style='color:#2F92EE;'>#神经疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74385, encryptionId=f587e438580, topicName=神经疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ea719457876, createdName=新生儿张玉军, createdTime=Thu Mar 20 04:13:00 CST 2014, time=2014-03-20, status=1, ipAttribution=)]